SOURCE: Alpharma Inc.

November 26, 2007 14:20 ET

Alpharma to Present at Lazard Fourth Annual Healthcare Conference

BRIDGEWATER, NJ--(Marketwire - November 26, 2007) - Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that Alpharma's senior management will provide an overview of the company's business at the Lazard Fourth Annual Healthcare Conference at The New York Palace on Wednesday, November 28, 2007 at 10:00AM Eastern Standard Time.

This presentation will be webcast live and can be accessed through Alpharma's website, through its Investor Support and Company Calendar tabs.

An archived version will be available for 90 days through February 25, 2008 after the live presentation and can be accessed at the same location.

Alpharma press releases are also available at our website:

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and an innovative pharmaceutical product pipeline that consists of several novel approaches to treat pain, including the FLECTOR® Patch (diclofenac epolamine topical patch), which is expected to launch in early 2008. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Contact Information